Patency comparison between two different kind of vascular accesses in hemodialysis patients.

Comparison of vascular patency in basilic vein transposition compared to straight 6-mm grafts, as upper arm vascular access, in hemodialysis patients.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016070726023N1

Enrollment

Registered

2016-10-13

Start date

2016-07-10

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Renal Failure. Chronic kidney disease, stage 5

Interventions

Intervention 1: Intervention group 1: in order to creating dialysis vascular access, surgical operation will be done to perform basilic vein transposition. In this group after explore and superficiali

Treatment - Surgery

Intervention group 1: in order to creating dialysis vascular access, surgical operation will be done to perform basilic vein transposition. In this group after explore and superficialisation of the b

Intervention group 2: Surgical operation for creating brachioaxillary prosthetic 6 mm graft between axillary vein and brachial artery. In this group after axillary vein and brachial artery exploration

Eligibility

Sex/Gender

All

Age

30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients Suffering end stage renal diseases with no possibility of creating the radiocephalic or brachiocephalic arteriovenous fistula for hemodialysis or they already have fistula but it has been damaged and unusable; No previous Basilic vein transposition or arteriovenous graft in the site of operation; No history of current medication with anticoagulants or antiplatelet agents; Age 30-80 years old. Exclusion criteria: Anticoagulant or antiplatelet treatment after surgery and during follows up; cease hemodialysis from the created access after the operation for any reason.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Access patency time. Timepoint: 2 weeks, 1, 2, 3, 6 months then every 3 months after surgery up to one year. Method of measurement: Observation for finding the evidence of created access obstruction or successful dialysis.	—

Secondary

Measure	Time frame
Presence of a palpable thrill in created access. Timepoint: 2 weeks, 1, 2, 3, 6 months then every 3 months after surgery up to one year. Method of measurement: Dialysis Access physical examination for thrill strength and consistency.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Pouya Tayebi

Mashhad University of Medical Sciences

tayebip941@mums.ac.ir+98 51 3841 2088

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026